Lymphome bei Kindern und Adoleszenten

Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36:1720–1748

Attarbaschi A, Abla O, Arias Padilla L et al (2020) Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‑cell lymphoma. Pediatr Blood Cancer 67:e28416

Attarbaschi A, Beishuizen A, Mann G et al (2013) Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a “watch and wait” strategy after complete resection. Ann Hematol 1(1):1537–1541. https://doi.org/10.1007/s00277-013-1785-2

Au-Yeung RKHK (2019) Features of Pediatric B‑lymphoblastic lymphoma with KMT2A rearrangements in the German NHL-BFM Group. In: The 108th Annual Meeting of the Japanese Society of Pathology. Proceedings of the Japanese Society of Pathology Tokyo, S 420

Au-Yeung RKH, Arias Padilla L, Zimmermann M et al (2020) Experience with provisional WHO-entities large B‑cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. https://doi.org/10.1111/bjh.16578

Beishuizen A, Mellgren K, Andrés M et al (2023) Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. Lancet Haematol 10:e213–e224

Burkhardt B, Michgehl U, Rohde J et al (2022) Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun 13:3881

Burkhardt B, Zimmermann M, Oschlies I et al (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 131:39–49

Jaffe E, H H, S H et al (2001) Pathology and genetics of tumours of haematopoetic and lymphoid tissues. IARC Press, Lyon, France

Klapper W, Kreuz M, Kohler CW et al (2012) Patient age at diagnosis is associated with the molecular characteristics of diffuse large B‑cell lymphoma. Blood 119:1882–1887

Kontny U, Oschlies I, Woessmann W et al (2015) Non-anaplastic peripheral T‑cell lymphoma in children and adolescents—a retrospective analysis of the NHL-BFM study group. Br J Haematol 168:835–844

Lamant L, Mccarthy K, D’amore E et al (2011) Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol 29:4669–4676

Laurent C, Cook JR, Yoshino T et al (2023) Follicular lymphoma and marginal zone lymphoma: how many diseases? Virchows Arch 482:149–162

Makarova O, Oschlies I, Muller S et al (2018) Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. Br J Haematol 182:735–739

Mauz-Körholz C, Lange T, Hasenclever D et al (2015) Pediatric nodular lymphocyte-predominant Hodgkin Lymphoma: treatment recommendations of the GPOH-HD study group. Klin Padiatr 227:314–321

Mauz-Körholz C, Metzger ML, Kelly KM et al (2015) Pediatric Hodgkin Lymphoma. J Clin Oncol 33:2975–2985

Minard-Colin V, Aupérin A, Pillon M et al (2020) Rituximab for High-Risk, Mature B‑Cell Non-Hodgkin’s Lymphoma in Children. N Engl J Med 382:2207–2219

Möker P, Zur Stadt U, Zimmermann M et al (2022) Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia. Leukemia 36:2343–2346

Mottok A, Hung SS, Chavez EA et al (2019) Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B‑cell lymphoma. Blood 134:802–813

Oschlies I, Burkhardt B, Chassagne-Clement C et al (2011) Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol 35:836–844

Oschlies I, Salaverria I, Mahn F et al (2009) Pediatric follicular lymphoma—a clinico-pathological study of a population-based series of patients treated within the NHL-BFM (Berlin-Frankfurt-Munster) multicenter trials. Haematologica 95(2):253–259. https://doi.org/10.3324/haematol.2009.013177

Richter J, John K, Staiger AM et al (2022) Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol 196:681–689

Salaverria I, Martin-Guerrero I, Wagener R et al (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B‑cell lymphomas resembling Burkitt lymphoma. Blood 123:1187–1198

Salaverria I, Philipp C, Oschlies I et al (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B‑cell lymphoma affecting predominantly children and young adults. Blood 118:139–147

Salmeron-Villalobos J, Egan C, Borgmann V et al (2022) A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile. Blood Adv 6:4661–4674

Sarkozy C, Chong L, Takata K et al (2020) Gene expression profiling of gray zone lymphoma. Blood Adv 4:2523–2535

Sarkozy C, Copie-Bergman C, Damotte D et al (2019) Gray-zone Lymphoma between cHL and large B‑cell Lymphoma: a Histopathologic series from the LYSA. Am J Surg Pathol 43:341–351

Sarkozy C, Hung SS, Chavez EA et al (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765–1776

Szczepanowski M, Lange J, Kohler CW et al (2017) Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B‑cell lymphoma of children and adolescents. Br J Haematol 179:116–119

Thomas N, Dreval K, Gerhard DS et al (2023) Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood 141:904–916

Woessmann W, Lisfeld J, Burkhardt B (2013) Therapy in primary mediastinal B‑cell lymphoma. N Engl J Med 369:282